Tidak mendapatkan kode? Kirim ulang atau Ubah Nomor Ponsel
Mohon Tunggu dalam Detik untuk kirim ulang
KHUSUS UNTUK DOKTER
Kelompok Percobaan Klinis C4591001. Keamanan, imunogenisitas, dan efikasi vaksin BNT162b2 COVID-19 pada remaja - Telaah Jurnal Alomedika
C4591001 Clinical Trial Group. Safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents.
Frenck RW Jr., Klein NP, Kitchin N, et al. N Engl J Med2021. doi:10.1056/NEJMoa2107456. pmid:34043894
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)
1. Frenck RW Jr., Klein NP, Kitchin N, et al., C4591001 Clinical Trial Group. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med2021. doi:10.1056/NEJMoa2107456. pmid:34043894
2. Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals. Juli 2021. Clinical trials.gov. U.S. National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04368728
3. Stamatatos, L., Czartoski, J., Wan, Y. H., et al. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science (New York, N.Y.), eabg 9175. 2021. Advance online publication. https://doi.org/10.1126/science.abg9175
Download Aplikasi Alomedika & Ikuti CME Online-nya!
Kumpulkan poin SKP sebanyak-banyaknya!
© 2024 Alomedika.com All Rights Reserved.
Facebook 
Masuk dengan Email
